Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof

Details for Australian Patent Application No. 2004231122 (hide)

Owner Xenon Pharmaceuticals Inc.

Inventors Ludwig, Erwin H.; Franchini, Patrick; Papanikolaou, George; Goldberg, Yigal Paul; MacDonald, Marcia L.E.; Kamboj, Rajender K.; Samuels, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-B-2004231122

PCT Pub. Number WO2004/092405

Priority 60/498,458 28.08.03 US; 60/488,607 18.07.03 US; 60/462,867 15.04.03 US

Filing date 8 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 8 April 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/092405 Priority application(s): WO2004/092405

8 April 2010 Application Accepted

  Published as AU-B-2004231122

5 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004231124-Polynucleotides for the detection of Listeria monocytogenes

2004231120-Determining gas volume, porosity, and intrinsic oxidation rate